Global Leukocyte Surface Antigen CD47 Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 160778
- Pages: 150
-
Format:
Summary
The global Leukocyte Surface Antigen CD47 market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
B-6H12
ALX-148
CC-90002
PSTx-23
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Aurigene Discovery Technologies Ltd
Celgene Corp
Forty Seven Inc
Surface Oncology Inc
Trillium Therapeutics Inc
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Lymphoma
Ovarian Cancer
Ischemia Reperfusion Injury
Kindney Transplant Rejection
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Leukocyte Surface Antigen CD47 of Research
1.1.1 Definition
1.1.2 Specifications of Leukocyte Surface Antigen CD47
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 B-6H12 Overview
1.2.1.2 ALX-148 Overview
1.2.1.3 CC-90002 Overview
1.2.1.4 PSTx-23 Overview
1.2.1.5 Others Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Lymphoma
1.3.1.2 Ovarian Cancer
1.3.1.3 Ischemia Reperfusion Injury
1.3.1.4 Kindney Transplant Rejection
1.3.1.5 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 B-6H12 Market Size 2018-2023
3.1.1.1 Global B-6H12 Market Size and Growth Rate 2018-2023
3.1.1.2 Global B-6H12 Market Size by Region 2018-2023
3.1.2 ALX-148 Market Size 2018-2023
3.1.2.1 Global ALX-148 Market Size and Growth Rate 2018-2023
3.1.2.2 Global ALX-148 Market Size by Region 2018-2023
3.1.3 CC-90002 Market Size 2018-2023
3.1.3.1 Global CC-90002 Market Size and Growth Rate 2018-2023
3.1.3.2 Global CC-90002 Market Size by Region 2018-2023
3.1.4 PSTx-23 Market Size 2018-2023
3.1.4.1 Global PSTx-23 Market Size and Growth Rate 2018-2023
3.1.4.2 Global PSTx-23 Market Size by Region 2018-2023
3.1.5 Others Market Size 2018-2023
3.1.5.1 Global Others Market Size and Growth Rate 2018-2023
3.1.5.2 Global Others Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 B-6H12 Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global B-6H12 Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global B-6H12 Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 ALX-148 Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global ALX-148 Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global ALX-148 Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 CC-90002 Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global CC-90002 Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global CC-90002 Market Estimates and Forecasts by Region 2024E-2030F
3.2.4 PSTx-23 Market Estimates and Forecasts 2024E-2030F
3.2.4.1 Global PSTx-23 Market Forecasts and Growth Rate 2024E-2030F
3.2.4.2 Global PSTx-23 Market Estimates and Forecasts by Region 2024E-2030F
3.2.5 Others Market Estimates and Forecasts 2024E-2030F
3.2.5.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
3.2.5.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Lymphoma Market Size 2018-2023
4.1.1.1 Global Lymphoma Market Size and Growth Rate 2018-2023
4.1.1.2 Global Lymphoma Market Size by Region 2018-2023
4.1.2 Ovarian Cancer Market Size 2018-2023
4.1.2.1 Global Ovarian Cancer Market Size and Growth Rate 2018-2023
4.1.2.2 Global Ovarian Cancer Market Size by Region 2018-2023
4.1.3 Ischemia Reperfusion Injury Market Size 2018-2023
4.1.3.1 Global Ischemia Reperfusion Injury Market Size and Growth Rate 2018-2023
4.1.3.2 Global Ischemia Reperfusion Injury Market Size by Region 2018-2023
4.1.4 Kindney Transplant Rejection Market Size 2018-2023
4.1.4.1 Global Kindney Transplant Rejection Market Size and Growth Rate 2018-2023
4.1.4.2 Global Kindney Transplant Rejection Market Size by Region 2018-2023
4.1.5 Others Market Size 2018-2023
4.1.5.1 Global Others Market Size and Growth Rate 2018-2023
4.1.5.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Lymphoma Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Lymphoma Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Lymphoma Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Ovarian Cancer Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Ovarian Cancer Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Ovarian Cancer Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Ischemia Reperfusion Injury Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Ischemia Reperfusion Injury Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Ischemia Reperfusion Injury Market Estimates and Forecasts by Region 2024E-2030F
4.2.4 Kindney Transplant Rejection Market Estimates and Forecasts 2024E-2030F
4.2.4.1 Global Kindney Transplant Rejection Market Forecasts and Growth Rate 2024E-2030F
4.2.4.2 Global Kindney Transplant Rejection Market Estimates and Forecasts by Region 2024E-2030F
4.2.5 Others Market Estimates and Forecasts 2024E-2030F
4.2.5.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.5.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Leukocyte Surface Antigen CD47 Market Competition
7.1.1 Global Leukocyte Surface Antigen CD47 Market by Companies
7.1.2 Global Leukocyte Surface Antigen CD47 Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Aurigene Discovery Technologies Ltd
8.1.1 Aurigene Discovery Technologies Ltd Company Profile
8.1.2 Aurigene Discovery Technologies Ltd Product Portfolio
8.1.3 Aurigene Discovery Technologies Ltd Business Performance
8.1.4 Aurigene Discovery Technologies Ltd Development Overview
8.2 Celgene Corp
8.2.1 Celgene Corp Company Profile
8.2.2 Celgene Corp Product Portfolio
8.2.3 Celgene Corp Business Performance
8.2.4 Celgene Corp Development Overview
8.3 Forty Seven Inc
8.3.1 Forty Seven Inc Company Profile
8.3.2 Forty Seven Inc Product Portfolio
8.3.3 Forty Seven Inc Business Performance
8.3.4 Forty Seven Inc Development Overview
8.4 Surface Oncology Inc
8.4.1 Surface Oncology Inc Company Profile
8.4.2 Surface Oncology Inc Product Portfolio
8.4.3 Surface Oncology Inc Business Performance
8.4.4 Surface Oncology Inc Development Overview
8.5 Trillium Therapeutics Inc
8.5.1 Trillium Therapeutics Inc Company Profile
8.5.2 Trillium Therapeutics Inc Product Portfolio
8.5.3 Trillium Therapeutics Inc Business Performance
8.5.4 Trillium Therapeutics Inc Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
